Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yu Y, Qi J, Xiong J, Jiang L, Cui D, He J, Chen P, Li L, Wu C, Ma T, Shao S, Wang J, Yu D, Zhou B, Huang D, Schmitt CA, Tao R.
Yu Y, et al. Among authors: jiang l.
Theranostics. 2019 Jan 24;9(3):761-777. doi: 10.7150/thno.29520. eCollection 2019.
Theranostics. 2019.
PMID: 30809307
Free PMC article.